Its allied organizations.

CCPM coalition people urge Congress to fix or drop the existing biogenerics provision The Coalition for a Competitive Pharmaceutical Market , its allied organizations, representing several hundred million Americans, join experts from the medical and research communities, economists and thought leaders appealing to Congress to repair the excessive 12-year market exclusivity and ever-greening provisions for biologics or drop it altogether. The letter, written with respect to older Americans, employees, businesses, and market stakeholders , implores Congress not to overlook the instant opportunity to bend the long-term price curve of health care through a workable pathway for biogenerics tablet every day .